Related Experiment Video

Updated: May 21, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

Comparison of inflammatory markers between diabetic and nondiabetic ST segment elevation myocardial infarction

Ji Man Heo1, Jae Hyoung Park, Ju Hyeon Kim

  • 1Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Seoul, Republic of Korea.

Journal of Cardiology
|June 5, 2012
PubMed

Insights

Patients with diabetes mellitus and ST-elevation myocardial infarction (STEMI) exhibit more severe inflammation than those with stable angina or non-diabetic STEMI. This highlights diabetes as a key factor in inflammatory responses during acute coronary syndromes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Immunology

Background:

  • Inflammation is a key factor in acute coronary syndrome (ACS) and type 2 diabetes mellitus (DM).
  • Investigating inflammatory differences between non-diabetic STEMI, diabetic stable angina (SA), and diabetic STEMI patients is crucial for understanding disease severity.
  • Previous observations suggest diabetic STEMI patients may experience more severe inflammatory changes.

Purpose of the Study:

  • To compare inflammation levels in non-diabetic STEMI and diabetic SA patients.
  • To determine if diabetic STEMI patients show more severe inflammatory changes than the other two groups.
  • To evaluate the role of inflammation and insulin resistance in different cardiovascular conditions.

Main Methods:

  • Comparison of inflammatory markers including highly sensitive C-reactive protein (hsCRP), erythrocyte sedimentation rate (ESR), interleukin-6 (IL-6), IL-18, vascular cell adhesion molecule-1 (VCAM-1), and matrix metallopeptidase-9 (MMP-9).
  • Assessment of insulin resistance using fasting insulin and homeostasis model assessment (HOMA).
  • Analysis of three patient groups: diabetic STEMI (90), diabetic SA (91), and non-diabetic STEMI (76).

Main Results:

  • No significant difference in inflammatory markers between diabetic SA and non-diabetic STEMI groups.
  • Diabetic STEMI patients showed increased hsCRP and IL-6 compared to diabetic SA patients (p=0.005, p=0.004).
  • Diabetic STEMI patients had elevated hsCRP, ESR, and IL-18 compared to non-diabetic STEMI patients (p=0.017, p=0.020, p=0.033).
  • Fasting insulin and HOMA were significantly higher in diabetic STEMI patients versus diabetic SA patients (p=0.04, p=0.004).

Conclusions:

  • Diabetic SA and non-diabetic STEMI patients may share similar inflammatory profiles.
  • Diabetic STEMI represents a more severe inflammatory state compared to diabetic SA or non-diabetic STEMI.
  • Inflammation and insulin resistance are critical factors differentiating the severity of coronary artery disease in diabetic patients.
Abstract

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...